Common (affecting up to 1 in 10 people, usually settling after a few weeks) Uncommon or rare (affecting up to 1 in 100 - or 1 in 1000 if rare - people, contact a doctor if severe) Nausea, diarrhoea, constipation, indigestion, tummy pain, reduced appetite, vomiting, injection-site reactions, dizziness, hair loss Gallstones,pancreatitis (severe abdominal or back pain),injection-site pain, serious allergy, changed sense of taste, change in skin sensation
Its worth noting that only Zepbound is FDA-approved for weight loss, while Mounjaro may be prescribed off-label for this purpose
Key takeaways Brand tirzepatide (Mounjaro & Zepbound) is fully FDA-approved, while compounded versions are mostly illegal in 2026
Compounded medications are prescription treatments custom-prepared by licensed pharmacies based on your providers clinical evaluation of your individual needs
Feb 24, 2026 Three approved sites
Exercise: Start with low to moderate activity, 150 minutes of walking, cycling, or swimming per week